Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
GNPX
#4509
Genprex, Inc. Common Stock
2.010
0
USD
+2.55%
Sektor:
Gesundheitswesen
Basis:
USD
Gewinnwährung:
USD
Tagesspanne
Jahresspanne
Tagesänderung
+2.55%
Monatliche Änderung
+7.49%
6 month change
+7.49%
Jahresänderung
+7.49%
Vorheriger Schlusskurs
1.960
0
Open
2.010
0
Bid
2.010
0
Ask
2.013
0
Low
2.010
0
High
2.010
0
Volumen
16
Märkte
Aktien
Gesundheitswesen
GNPX
Open full chart
Financials
Overview
Finanzbericht
Statistics
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
170.16 K
483.06 K
556.42 K
669.34 K
2.27 M
—
Valuation ratios
Enterprise value
-1.43 M
-1.19 M
-3.33 M
-1.19 M
-718.72 K
-6.44 M
Price to earnings ratio
-0
-0
-0
-0
-0
-0.01
Price to sales ratio
-0.75
—
-14.6
-92.84
26.93
—
Price to cash flow ratio
-0
-0
-0
-0
-0
-0.01
Price to book ratio
0
0.04
0
0
0
0.05
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-1.1
-1.05
-0.66
-1.22
-1.07
-4
Return on equity %
-2.59
-2.67
-1.03
-3.36
-4.95
-12.01
Return on invested capital %
—
—
—
—
—
—
Gross margin %
100
100
100
100
100
400
Operating margin %
687.35 K
-797.01 K
4.96 M
-234.09 M
1.83 M
-228.1 M
EBITDA margin %
—
—
—
—
—
—
Net margin %
686.17 K
-796.04 K
4.96 M
-233.75 M
2.08 M
-227.51 M
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
0.86
0.83
1.94
0.84
0.67
4.29
Inventory turnover
—
—
—
—
—
—
Asset turnover
-0
0
-0
0
-0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-20.18
-38.64
-13.63
-7
-4.19
-63.46
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
21.26
19.99
11.36
2.44
1.45
35.24
Net current asset value per share
27.39
25.93
13.64
3.73
2.26
45.55
Tangible book value per share
23.79
20.22
12.67
2.52
1.01
36.42
Working capital per share
-4.64
-5.33
6.62
-0.69
-1.1
-0.49
Book value per share
23.79
20.22
12.67
2.52
1.01
36.42
Nachrichten
Patentzulassungen in Japan und Europa beflügeln Genprex-Aktie
Genprex stock jumps on Japan, Europe patent approvals
Genprex sichert sich Patente für Krebstherapie in Japan und Europa/n
Genprex receives Japanese and European patents for cancer therapy
Genprex receives patent approval in Australia for cancer therapy
Genprex reports positive data for diabetes gene therapy in animal studies
Genprex reports potential compliance with Nasdaq equity listing rule
Genprex reports phase 1 data for lung cancer gene therapy
Genprex reicht Prospektnachtrag für At-the-Market-Offering über bis zu 75 Mio. US-Dollar ein
Genprex receives US patent for cancer therapy combination
Genprex erhält europäisches Patent für kombinierte Krebs-Gentherapie
Genprex to receive European patent for cancer gene therapy combination